These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15911796)

  • 21. Hallucinations in Parkinson's disease: a follow-up study.
    de Maindreville AD; Fénelon G; Mahieux F
    Mov Disord; 2005 Feb; 20(2):212-7. PubMed ID: 15390044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal study.
    Kurz MW; Schlitter AM; Klenk Y; Mueller T; Larsen JP; Aarsland D; Dekomien G
    J Geriatr Psychiatry Neurol; 2007 Jun; 20(2):89-92. PubMed ID: 17548778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.
    Hobson P; Meara J
    Mov Disord; 2004 Sep; 19(9):1043-9. PubMed ID: 15372593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.
    Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
    Neurol Neurochir Pol; 2007; 41(2):113-21. PubMed ID: 17530572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of age of onset and family history in Parkinson disease.
    Barrett MJ; Hac NE; Yan G; Harrison MB; Wooten GF
    Mov Disord; 2015 Apr; 30(5):733-5. PubMed ID: 25737058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease and narcolepsy-like symptoms.
    Ylikoski A; Martikainen K; Sarkanen T; Partinen M
    Sleep Med; 2015 Apr; 16(4):540-4. PubMed ID: 25770044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study.
    Bjornestad A; Pedersen KF; Tysnes OB; Alves G
    Parkinsonism Relat Disord; 2017 Sep; 42():28-33. PubMed ID: 28578818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study.
    Williams DR; Lees AJ
    Lancet Neurol; 2005 Oct; 4(10):605-10. PubMed ID: 16168928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation.
    Tan LC; Tanner CM; Chen R; Chan P; Farrer M; Hardy J; Langston JW
    Mov Disord; 2003 Jul; 18(7):758-63. PubMed ID: 12815654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
    Sinha R; Racette B; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella CL; Nance MA; Bressman SB; Scott WK; Tanner CM; Mickel SF; Waters CH; Fahn S; Cote LJ; Frucht SJ; Ford B; Rezak M; Novak KE; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Payami H; Molho E; Factor SA; Nutt JG; Serrano C; Arroyo M; Ottman R; Pauciulo MW; Nichols WC; Clark LN; Marder KS
    JAMA Neurol; 2014 Jan; 71(1):62-7. PubMed ID: 24190026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
    Cubo E; González M; Aguilar A; Quintana S
    Neurologia; 2006; 21(1):12-8. PubMed ID: 16525921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual complaints and visual hallucinations in Parkinson's disease.
    Urwyler P; Nef T; Killen A; Collerton D; Thomas A; Burn D; McKeith I; Mosimann UP
    Parkinsonism Relat Disord; 2014 Mar; 20(3):318-22. PubMed ID: 24405755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.
    Ghione I; Di Fonzo A; Saladino F; Del Bo R; Bresolin N; Comi GP; Rango M
    Neurotoxicology; 2007 May; 28(3):698-701. PubMed ID: 17335904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient and Informant Views on Visual Hallucinations in Parkinson Disease.
    Urwyler P; Nef T; Müri RM; Killen A; Collerton D; Burn D; McKeith I; Mosimann UP
    Am J Geriatr Psychiatry; 2015 Sep; 23(9):970-6. PubMed ID: 25623941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dementia in Parkinson's disease: a post-mortem study in a population of brain donors.
    Papapetropoulos S; Gonzalez J; Lieberman A; Villar JM; Mash DC
    Int J Geriatr Psychiatry; 2005 May; 20(5):418-22. PubMed ID: 15852454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RBD in Parkinson's disease: a clinical case control study from North India.
    Vibha D; Shukla G; Goyal V; Singh S; Srivastava AK; Behari M
    Clin Neurol Neurosurg; 2011 Jul; 113(6):472-6. PubMed ID: 21414715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence and the associated factors of dementia in patients with Parkinson's disease at Maharat Nakhon Ratchasima Hospital.
    Mekawichai P; Choeikamhaeng L
    J Med Assoc Thai; 2013 Apr; 96(4):440-5. PubMed ID: 23691698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical phenotype of Parkinson disease dementia.
    Galvin JE; Pollack J; Morris JC
    Neurology; 2006 Nov; 67(9):1605-11. PubMed ID: 17101891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.